Spreewälder Arzneimittel Overview

  • Founded
  • 1949

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Spreewälder Arzneimittel General Information


Developer of pharmaceutical products intended to develop medicines for dry skin conditions patients. The company develops products for condition such as psoriasis, eczema, atopic dermatitis and neurodermatitis.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Parent Company
Primary Office
  • Schulstraße 9
  • 15913 Markische Heide
  • Germany
+49 035476 00000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spreewälder Arzneimittel Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Spreewälder Arzneimittel‘s full profile, request access.

Request a free trial

Spreewälder Arzneimittel Executive Team (2)

Name Title Board Seat Contact Info
Adam Swideski Managing Director
You’re viewing 1 of 2 executive team members. Get the full list »